APA:
Copy. (2017). Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in hemodialysis patients. MEDICINA, 53(2), 90-100. SID. https://sid.ir/paper/735115/en
Vancouver:
Copy. Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in hemodialysis patients. MEDICINA[Internet]. 2017;53(2):90-100. Available from: https://sid.ir/paper/735115/en
IEEE:
Copy, “Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in hemodialysis patients,” MEDICINA, vol. 53, no. 2, pp. 90–100, 2017, [Online]. Available: https://sid.ir/paper/735115/en